by Dennis Thompson, Healthday Reporter
But experts aren't suggesting patients strive for higher-than-normal levels.
(HealthDay)—Higher vitamin D levels in patients with advanced colon cancer appear to improve response to chemotherapy and targeted anti-cancer drugs, researchers say.
"We found that patients who had vitamin D levels at the highest category had improved survival and improved progression-free survival, compared with patients in the lowest category," said lead author Dr. Kimmie Ng, an assistant professor of medicine at Harvard Medical School in Boston.
Those patients survived one-third longer than patients with low levels of vitamin D—an average 32.6 months, compared with 24.5 months, the researchers found.
The report, scheduled for presentation this week at the Gastrointestinal Cancers Symposium in San Francisco, adds more weight to suspicions that vitamin D might be a valuable cancer-fighting supplement.
However, colon cancer patients shouldn't try to boost vitamin D levels beyond the normal range, one expert said.
The study only found an association between vitamin D levels and colon cancer survival rates. It did not prove cause and effect.
Researchers for years have investigated vitamin D as a potential anti-cancer tool, but none of the findings have been strong enough to warrant a recommendation, said Dr. Len Lichtenfeld, deputy chief medical officer for the American Cancer Society.
"Everyone comes to the same conclusion—yes, there may be some benefit, but we really need to study it carefully so we can be certain there aren't other factors that make vitamin D look better than it is," Lichtenfeld said. "These findings are interesting, and show that vitamin D may have a role in improving outcomes in cancer care."
In this study, researchers measured blood levels of vitamin D in 1,043 patients enrolled in a phase 3 clinical trial comparing three first-line treatments for newly diagnosed, advanced colon cancer. All of the treatments involved chemotherapy combined with the targeted anti-cancer drugs bevacizumab and/or cetuximab.
Vitamin D is called the "sunshine vitamin" because human bodies produce it when the sun's ultraviolet rays strike the skin. It promotes the intestines' ability to absorb calcium and other important minerals, and is essential for maintaining strong, healthy bones, according to the U.S. National Institutes of Health.
But vitamin D also influences cellular function in ways that could be beneficial in treating cancer, Ng said. For example, she said it appears to reduce cell growth, promote the death of diseased cells, and inhibit the formation of new blood vessels to feed cancerous tumors.
The study authors found that certain types of cancer patients tended to have lower vitamin D levels. These included people whose blood specimens were drawn in the winter and spring months, people who live in the northern and northeastern states, older adults, blacks, overweight or obese people, and those who had lower physical activity and were in worse physical condition.
The patients were divided into five groups based on vitamin D levels, ranging from low to high. After adjusting for prognosis and healthy behaviors, the researchers found that patients in the group with the highest levels of vitamin D lived about eight months longer on average than those in the group with the lowest levels.
"We had a lot of information on their tumor, their treatment and their survival times, and their diet and lifestyle," Ng said. "That really allowed us to adjust for other potential factors that could influence what we're seeing."
It also took longer for cancer to progress in people with higher vitamin D levels—an average 12.2 months compared with about 10 months in the group with the lowest. No significant differences were seen with regard to the type of therapy the patients received.
This increase in progression-free survival is the most compelling evidence indicating that vitamin D makes a difference in colon cancer, said Dr. Smitha Krishnamurthi, an associate professor of hematology and oncology at Case Western Reserve University School of Medicine in Cleveland.
"That is interesting because that's more of a cancer-specific endpoint as opposed to overall survival, which could be influenced by other factors like heart health," Krishnamurthi said.
Everyone should maintain healthy vitamin D levels anyway, to protect their bone health, Ng and Krishnamurthi said.
Based on this new study, Krishnamurthi said she would emphasize the importance of vitamin D for patients with colon cancer.
"They should take supplements to bring it into normal range, because we know it is good for bone health and it may have an anti-cancer effect," she said.
However, "if someone has a normal vitamin D level, I wouldn't take supplements to increase it because we won't know the true effect on cancer until we see the results of a clinical trial," she said.
The U.S. National Institutes of Health funded the study. Research presented at meetings is considered preliminary until published in a peer-reviewed medical journal.
Explore further: Sunshine vitamin ups bowel cancer survival odds, study finds
More information: For more on vitamin D and cancer, visit the U.S. National Cancer Institute.
Copyright © 2015 HealthDay. All rights reserved.
Medical Xpress on facebook
Related Stories
Sunshine vitamin ups bowel cancer survival odds, study finds
Jul 09, 2014
Bowel cancer patients with high levels of vitamin D in their blood are more likely to survive the disease, a study shows.
Vitamin D may raise survival rates among cancer patients
Apr 29, 2014
Cancer patients who have higher levels of vitamin D when they are diagnosed tend to have better survival rates and remain in remission longer than patients who are vitamin D-deficient, according to a new study published in ...
Vitamin D may play an important role in cancer prognosis
Jun 17, 2014
Researchers have found that people with very low levels of vitamin D appear to be at higher risk of death from all causes (including cancer) and say that vitamin D could play an important role in cancer prognosis in a paper ...
Vitamin D deficiency common in cancer patients
Oct 03, 2011
More than three-quarters of cancer patients have insufficient levels of vitamin D (25-hydroxy-vitamin D) and the lowest levels are associated with more advanced cancer, according to a study presented on October 2, 2011, at ...
Vitamin D deficiency raises risk of schizophrenia diagnosis
Jul 22, 2014
Vitamin D-deficient individuals are twice as likely to be diagnosed with schizophrenia as people who have sufficient levels of the vitamin, according to a new study published in the Endocrine Society's Journal of ...
Recommended for you
FDA approved drug extends survival for patients with rare cancer
8 hours ago
Sunitinib, an agent approved for use in several cancers, provides unprecedented antitumor activity in thymic carcinoma, a rare but aggressive tumor of the thymus gland, according to a phase II clinical trial led by a researcher ...
'Survival' protein a target in drug-resistant non-Hodgkin lymphomas
11 hours ago
Melbourne researchers have discovered that targeting a cell 'survival' protein could help treat some lymphomas, including those cancers with genetic defects that make them resistant to many existing therapies.
Study identifies new gene mutations linked to colorectal cancer in African-Americans
12 hours ago
Case Comprehensive Cancer Center researchers have identified new gene mutations unique to colon cancers in African Americans - the population with the highest incidence and death rates of any group for this ...
Revisions to molecular testing guideline continues to give hope to lung cancer patients
14 hours ago
The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) are teaming to revise the evidence-based guideline, "Molecular ...
Beyond prevention: Sulforaphane may find possible use for cancer therapy
14 hours ago
New research has identified one of the key cancer-fighting mechanisms for sulforaphane, and suggests that this much-studied phytochemical may be able to move beyond cancer prevention and toward therapeutic ...
Researchers discover mechanism leading to drug resistance, metastasis in melanoma
16 hours ago
Moffitt Cancer Center researchers have discovered a mechanism that leads to resistance to targeted therapy in melanoma patients and are investigating strategies to counteract it. Targeted biological therapy can reduce toxicity ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
by Dennis Thompson, Healthday Reporter
But experts aren't suggesting patients strive for higher-than-normal levels.
(HealthDay)—Higher vitamin D levels in patients with advanced colon cancer appear to improve response to chemotherapy and targeted anti-cancer drugs, researchers say.
"We found that patients who had vitamin D levels at the highest category had improved survival and improved progression-free survival, compared with patients in the lowest category," said lead author Dr. Kimmie Ng, an assistant professor of medicine at Harvard Medical School in Boston.
Those patients survived one-third longer than patients with low levels of vitamin D—an average 32.6 months, compared with 24.5 months, the researchers found.
The report, scheduled for presentation this week at the Gastrointestinal Cancers Symposium in San Francisco, adds more weight to suspicions that vitamin D might be a valuable cancer-fighting supplement.
However, colon cancer patients shouldn't try to boost vitamin D levels beyond the normal range, one expert said.
The study only found an association between vitamin D levels and colon cancer survival rates. It did not prove cause and effect.
Researchers for years have investigated vitamin D as a potential anti-cancer tool, but none of the findings have been strong enough to warrant a recommendation, said Dr. Len Lichtenfeld, deputy chief medical officer for the American Cancer Society.
"Everyone comes to the same conclusion—yes, there may be some benefit, but we really need to study it carefully so we can be certain there aren't other factors that make vitamin D look better than it is," Lichtenfeld said. "These findings are interesting, and show that vitamin D may have a role in improving outcomes in cancer care."
In this study, researchers measured blood levels of vitamin D in 1,043 patients enrolled in a phase 3 clinical trial comparing three first-line treatments for newly diagnosed, advanced colon cancer. All of the treatments involved chemotherapy combined with the targeted anti-cancer drugs bevacizumab and/or cetuximab.
Vitamin D is called the "sunshine vitamin" because human bodies produce it when the sun's ultraviolet rays strike the skin. It promotes the intestines' ability to absorb calcium and other important minerals, and is essential for maintaining strong, healthy bones, according to the U.S. National Institutes of Health.
But vitamin D also influences cellular function in ways that could be beneficial in treating cancer, Ng said. For example, she said it appears to reduce cell growth, promote the death of diseased cells, and inhibit the formation of new blood vessels to feed cancerous tumors.
The study authors found that certain types of cancer patients tended to have lower vitamin D levels. These included people whose blood specimens were drawn in the winter and spring months, people who live in the northern and northeastern states, older adults, blacks, overweight or obese people, and those who had lower physical activity and were in worse physical condition.
The patients were divided into five groups based on vitamin D levels, ranging from low to high. After adjusting for prognosis and healthy behaviors, the researchers found that patients in the group with the highest levels of vitamin D lived about eight months longer on average than those in the group with the lowest levels.
"We had a lot of information on their tumor, their treatment and their survival times, and their diet and lifestyle," Ng said. "That really allowed us to adjust for other potential factors that could influence what we're seeing."
It also took longer for cancer to progress in people with higher vitamin D levels—an average 12.2 months compared with about 10 months in the group with the lowest. No significant differences were seen with regard to the type of therapy the patients received.
This increase in progression-free survival is the most compelling evidence indicating that vitamin D makes a difference in colon cancer, said Dr. Smitha Krishnamurthi, an associate professor of hematology and oncology at Case Western Reserve University School of Medicine in Cleveland.
"That is interesting because that's more of a cancer-specific endpoint as opposed to overall survival, which could be influenced by other factors like heart health," Krishnamurthi said.
Everyone should maintain healthy vitamin D levels anyway, to protect their bone health, Ng and Krishnamurthi said.
Based on this new study, Krishnamurthi said she would emphasize the importance of vitamin D for patients with colon cancer.
"They should take supplements to bring it into normal range, because we know it is good for bone health and it may have an anti-cancer effect," she said.
However, "if someone has a normal vitamin D level, I wouldn't take supplements to increase it because we won't know the true effect on cancer until we see the results of a clinical trial," she said.
The U.S. National Institutes of Health funded the study. Research presented at meetings is considered preliminary until published in a peer-reviewed medical journal.
Explore further: Sunshine vitamin ups bowel cancer survival odds, study finds
More information: For more on vitamin D and cancer, visit the U.S. National Cancer Institute.
Copyright © 2015 HealthDay. All rights reserved.
Medical Xpress on facebook
Related Stories
Sunshine vitamin ups bowel cancer survival odds, study finds
Jul 09, 2014
Bowel cancer patients with high levels of vitamin D in their blood are more likely to survive the disease, a study shows.
Vitamin D may raise survival rates among cancer patients
Apr 29, 2014
Cancer patients who have higher levels of vitamin D when they are diagnosed tend to have better survival rates and remain in remission longer than patients who are vitamin D-deficient, according to a new study published in ...
Vitamin D may play an important role in cancer prognosis
Jun 17, 2014
Researchers have found that people with very low levels of vitamin D appear to be at higher risk of death from all causes (including cancer) and say that vitamin D could play an important role in cancer prognosis in a paper ...
Vitamin D deficiency common in cancer patients
Oct 03, 2011
More than three-quarters of cancer patients have insufficient levels of vitamin D (25-hydroxy-vitamin D) and the lowest levels are associated with more advanced cancer, according to a study presented on October 2, 2011, at ...
Vitamin D deficiency raises risk of schizophrenia diagnosis
Jul 22, 2014
Vitamin D-deficient individuals are twice as likely to be diagnosed with schizophrenia as people who have sufficient levels of the vitamin, according to a new study published in the Endocrine Society's Journal of ...
Recommended for you
FDA approved drug extends survival for patients with rare cancer
8 hours ago
Sunitinib, an agent approved for use in several cancers, provides unprecedented antitumor activity in thymic carcinoma, a rare but aggressive tumor of the thymus gland, according to a phase II clinical trial led by a researcher ...
'Survival' protein a target in drug-resistant non-Hodgkin lymphomas
11 hours ago
Melbourne researchers have discovered that targeting a cell 'survival' protein could help treat some lymphomas, including those cancers with genetic defects that make them resistant to many existing therapies.
Study identifies new gene mutations linked to colorectal cancer in African-Americans
12 hours ago
Case Comprehensive Cancer Center researchers have identified new gene mutations unique to colon cancers in African Americans - the population with the highest incidence and death rates of any group for this ...
Revisions to molecular testing guideline continues to give hope to lung cancer patients
14 hours ago
The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) are teaming to revise the evidence-based guideline, "Molecular ...
Beyond prevention: Sulforaphane may find possible use for cancer therapy
14 hours ago
New research has identified one of the key cancer-fighting mechanisms for sulforaphane, and suggests that this much-studied phytochemical may be able to move beyond cancer prevention and toward therapeutic ...
Researchers discover mechanism leading to drug resistance, metastasis in melanoma
16 hours ago
Moffitt Cancer Center researchers have discovered a mechanism that leads to resistance to targeted therapy in melanoma patients and are investigating strategies to counteract it. Targeted biological therapy can reduce toxicity ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment